Table 1.
Tear sample grouping based on wound healing stages for both wounded and procedural control eyes.
Table 2.
MMP-2 and MMP-9 activity in tears.
Figure 1.
MMP-2 expression in ocular surface tissues.
Representative light micrographs of tissue sections showing MMP-2 expression (A–D) corneal epithelium, (E–H) stromal keratocytes, (I–L) bulbar conjunctival epithelium, (M–P) lacrimal gland and (Q–T) meibomian gland of unwounded control eyes collected prior to surgery and wounded eyes at various phases of healing. Arrows indicate stromal keratocytes. Arrow head shows an example of a conjunctival goblet cell.
Figure 2.
MMP-9 expression in ocular surface tissues.
Representative light micrographs of tissue sections showing MMP-9 expression in (A–D) corneal epithelium, (E–H) stromal keratocytes, (I–L) bulbar conjunctival epithelium, (M–P) lacrimal gland and (Q–T) meibomian gland of unwounded control eyes collected prior to surgery, and wounded eyes at various stages of healing. Arrows indicate stromal keratocytes. Arrow head shows an example of a conjunctival goblet cell.
Figure 3.
MMP-2 and MMP-9 expression in conjunctival associated lymphoid tissue (CALT) in the palpebral conjunctiva.
Representative light micrographs of a section through CALT showing (A) MMP-2, (B) MMP-9 expression and (C) IgG control, at the time of corneal wound closure.